He was first suspected of having COVID-19 pneumonia, but then the right diagnosis of Pneumocystis Jiroveci pneumonia was made and this needed timely decision making in order not to lose the patient.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The novel coronavirus SARS-CoV-2 that first appeared in December 2019 has threatened the world in a matter of months.
📊
Key Findings & Data:The preoccupation by the risk of this disease might mislead the clinician and distract him from providing the best care for his patients who are as well exposed to other risks and conditions.
💡
Conclusion & Impact:He was first suspected of having COVID-19 pneumonia, but then the right diagnosis of Pneumocystis Jiroveci pneumonia was made and this needed timely decision making in order not to lose the patient.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Özet
The novel coronavirus SARS-CoV-2 that first appeared in December 2019 has threatened the world in a matter of months. The preoccupation by the risk of this disease might mislead the clinician and distract him from providing the best care for his patients who are as well exposed to other risks and conditions. We report in this article the case of a metastatic melanoma patient treated with immunotherapy, who presented for fever, respiratory symptoms and a diffuse bilateral lung infiltration with ground glass opacities. He was first suspected of having COVID-19 pneumonia, but then the right diagnosis of Pneumocystis Jiroveci pneumonia was made and this needed timely decision making in order not to lose the patient.
🔖
Cite This Article
MOUJAESS, E., HADDAD, E. E., KATTAN, J. (2020). Pneumocystis Jiroveci Mimicking COVID-19 Pneumonia in a Patient who is Receiving Ipilimumab and Nivolumab Combination Therapy: A Case Report. Eurasian Journal of Medicine and Oncology, Cilt: 4 - Sayı: 3, 246–250. https://ajindex.com/articles/125150
WHO Timeline - COVID-19 [Internet]. [cited 2020 Apr 17]. Available from: https://www.who.int/news-room/detail/08- 04-2020-who-timeline---covid-19 2. Wang Z, Wang J, He J. Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China. JAMA Oncol. 2020 Apr 1. 3. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020
335–7. 4. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020 Mar 25. 5. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol 2020
S0923753420363833. 6. Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol Off J Eur Soc Med Oncol. 2020 Mar 19. 7. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med 2015
23–34. 8. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19. Ann Intern Med. 2020 Mar 27. 9. moph [Internet]. [cited 2020 Apr 17]. Available from: http:// www.moph.gov.lb 10. Liang W-H, Guan W-J, Li C-C, Li Y-M, Liang H-R, Zhao Y, et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China. Eur Respir J. 2020 Apr 8. 11. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020
NEJMoa2002032. 12. Zhou S, Wang Y, Zhu T, Xia L. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. Am J Roentgenol 2020
1–8. 13. Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, et al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology 2020
200843. 14. Qu J, Yang R, Song L, Kamel IR. Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19. Ann Oncol Off J Eur Soc Med Oncol 2020 Mar 9. 15. Kattan J, Kattan C, Assi T. Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 i